Literature DB >> 20156658

NF-kappaB1 contributes to T cell-mediated control of Toxoplasma gondii in the CNS.

Tajie H Harris1, Emma H Wilson, Elia D Tait, Marie Buckley, Sagi Shapira, Jorge Caamano, David Artis, Christopher A Hunter.   

Abstract

In this study, the role of NF-kappaB1 was examined during toxoplasmosis. While wildtype BALB/c mice generated protective responses, NF-kappaB1(-/-) mice developed Toxoplasmic encephalitis, characterized by increased parasite burden and necrosis in the brain. Susceptibility was primarily associated with a local decrease in the number of CD8(+) T cells and IFN-gamma production, while accessory cell function appeared intact in NF-kappaB1(-/-) mice. Consistent with these findings, T cell transfer studies revealed that NF-kappaB1(-/-) T cells provided SCID mice less protection than wildtype T cells. These results demonstrate an intrinsic role for NF-kappaB1 in T cell-mediated immunity to Toxoplasmagondii. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156658      PMCID: PMC2860689          DOI: 10.1016/j.jneuroim.2009.12.009

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  54 in total

1.  Cutting edge: identification of c-Rel-dependent and -independent pathways of IL-12 production during infectious and inflammatory stimuli.

Authors:  Nicola Mason; Julio Aliberti; Jorge C Caamano; Hsiou-Chi Liou; Christopher A Hunter
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

2.  Suppression of NF-kappaB activation by infection with Toxoplasma gondii.

Authors:  S Shapira; K Speirs; A Gerstein; J Caamano; C A Hunter
Journal:  J Infect Dis       Date:  2002-02-15       Impact factor: 5.226

Review 3.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 4.  Rel/NF-kappa B and I kappa B proteins: an overview.

Authors:  M J May; S Ghosh
Journal:  Semin Cancer Biol       Date:  1997-04       Impact factor: 15.707

5.  Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-kappa B.

Authors:  B A Butcher; L Kim; P F Johnson; E Y Denkers
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

6.  Differential requirement for NF-kappa B family members in control of helminth infection and intestinal inflammation.

Authors:  David Artis; Sagi Shapira; Nicola Mason; Kendra M Speirs; Michael Goldschmidt; Jorge Caamaño; Hsiou-Chi Liou; Christopher A Hunter; Phillip Scott
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

7.  Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation.

Authors:  Brendan A Hilliard; Nicola Mason; Lingyun Xu; Jing Sun; Salah-Eddine Lamhamedi-Cherradi; Hsiou-Chi Liou; Christopher Hunter; Youhai H Chen
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.

Authors:  Charles A Scanga; Julio Aliberti; Dragana Jankovic; Florence Tilloy; Soumaya Bennouna; Eric Y Denkers; Ruslan Medzhitov; Alan Sher
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

Review 9.  NF-kappaB regulation in the immune system.

Authors:  Qiutang Li; Inder M Verma
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

10.  Proteolysis of NF-kappaB1 p105 is essential for T cell antigen receptor-induced proliferation.

Authors:  Srividya Sriskantharajah; Monica P Belich; Stamatia Papoutsopoulou; Julia Janzen; Victor Tybulewicz; Benedict Seddon; Steven C Ley
Journal:  Nat Immunol       Date:  2008-12-07       Impact factor: 25.606

View more
  13 in total

1.  Role of the NF-κB transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondii.

Authors:  Kimberly A Jordan; Christopher D Dupont; Elia D Tait; Hsiou-Chi Liou; Christopher A Hunter
Journal:  Int Immunol       Date:  2010-11       Impact factor: 4.823

Review 2.  Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Authors:  Yasuhiro Suzuki; Qila Sa; Marie Gehman; Eri Ochiai
Journal:  Expert Rev Mol Med       Date:  2011-10-04       Impact factor: 5.600

Review 3.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Cooperation of TLR12 and TLR11 in the IRF8-dependent IL-12 response to Toxoplasma gondii profilin.

Authors:  Megan Raetz; Alexey Kibardin; Carolyn R Sturge; Reed Pifer; Haiying Li; Ezra Burstein; Keiko Ozato; Sergey Larin; Felix Yarovinsky
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

5.  Toxoplasma gondii virulence factor ROP18 inhibits the host NF-κB pathway by promoting p65 degradation.

Authors:  Jian Du; Ran An; Lijian Chen; Yuxian Shen; Ying Chen; Li Cheng; Zhongru Jiang; Aimei Zhang; Li Yu; Deyong Chu; Yujun Shen; Qingli Luo; He Chen; Lijuan Wan; Min Li; Xiucai Xu; Jilong Shen
Journal:  J Biol Chem       Date:  2014-03-19       Impact factor: 5.157

6.  Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection.

Authors:  Sushrut Kamerkar; Paul H Davis
Journal:  J Parasitol Res       Date:  2012-03-22

7.  Dissecting Amyloid Beta Deposition Using Distinct Strains of the Neurotropic Parasite Toxoplasma gondii as a Novel Tool.

Authors:  Carla M Cabral; Kathryn E McGovern; Wes R MacDonald; Jenna Franco; Anita A Koshy
Journal:  ASN Neuro       Date:  2017 Jul-Aug       Impact factor: 4.146

8.  Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice.

Authors:  Ragab M Fereig; Yasuhiro Kuroda; Mohamad Alaa Terkawi; Motamed Elsayed Mahmoud; Yoshifumi Nishikawa
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

9.  MyD88 is crucial for the development of a protective CNS immune response to Toxoplasma gondii infection.

Authors:  Marbel Torres; Rachel Guiton; Sonia Lacroix-Lamandé; Bernhard Ryffel; Samuel Leman; Isabelle Dimier-Poisson
Journal:  J Neuroinflammation       Date:  2013-02-01       Impact factor: 8.322

10.  Characteristics of Infection Immunity Regulated by Toxoplasma gondii to Maintain Chronic Infection in the Brain.

Authors:  Young Sang Hwang; Ji-Hun Shin; Jung-Pyo Yang; Bong-Kwang Jung; Sang Hyung Lee; Eun-Hee Shin
Journal:  Front Immunol       Date:  2018-02-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.